Astal Laboratories

Founded in 1993, Astal Laboratories Limited has recently entered the pharmaceutical industry as a dynamic new player in the bulk drug manufacturing segment. The company's mission is to address global healthcare challenges by delivering superior products, aiming to make a meaningful impact on health outcomes worldwide. It is strongly committed to meeting the growing global demand for essential pharmaceutical ingredients with a focus on quality, efficiency, and sustainability. Its business is entirely focused on producing Pharmaceutical Bulk Drugs, which are Active Pharma Ingredients (APIs), and Key Starting Materials or Intermediates. A key part of its strategy includes forging strategic alliances with like-minded organizations and investing in talent to foster a culture of excellence and growth. This new business focus has led to substantial results, with revenue from operations growing by 589.82% in the past financial year.;